Today's New Buy Pick - Molecular Templates, Inc. (MTEM)

[Learn The # 1 Key To Successful Stock Investing]( - [Click Here Now](  __________________________________________________ Why David Tepper Says The Coronavirus Is A “Game Changer” For Stocks...  "It is big. It’s going to  paralyze China. It’s going to cascade throughout the global economy. …  We should pay more attention to this. And we should try and resist our  inclination to buy the dip.” International Business Machines (NYSE: [IBM](  IBM shares gained 5% after it announced that president and CEO Virginia  Rometty would be leaving her post at the beginning of April, and will  be replaced by Arvind Krishna. Instinet analyst Jeffrey Kvaal said that  the management change is “an opportunity for IBM to... [Read More]( [Flip $500 into $650,000 (without risking a PENNY on stocks)]( Former Lehman Brothers executive reveals one of Wall Street's best kept secrets. A proven system for turning $500 into $650,000 (or more) - without touching the stock market. In fact, this system is responsible for the most profitable investment of all time! (ad) [Click here for details >>](  [Recluse Trader's Shocking 109% Gain In 2019 - Without Options]( Underground  trader Shane Rawlings uses a weird niche pattern to grow his portfolio  109% in 2019 (without options).  Consider: $10,000 compounded at 109%  swells to $1,741,903 in only 7 years.  After 10 years it’s worth a  staggering $15,902,406.  For the first time ever Shane is going public  with all the details behind this pattern.  [Click here to start using  this pattern in your own trading](  [JNPR is down -13% in the last three months. Is it a good buy now?]( The market has gotten pretty shaky over the last couple of weeks, with a  lot of investors getting even more nervous to close out the week this  last Friday. The World Health Organization (WHO) declared coronavirus a  global emergency at the end of the week, which seems to be something  that the market is simply using to keep uncertainty high. That’s  prompted the broad market to drop by about 4% from its latest high, and  into territory that has analysts and talking heads starting to use terms  like “correction.”  [Read More](  [Stock Market algorithm makes shockingly accurate predictions]( A software expert has created an algorithm that detects stock market trends with shocking accuracy. It's creator, Tom Gentile, is giving common people who are invested (or interested in investing) in the stock market, a rare chance to access the recommendations he finds using this system. A system which allows you to circle a date on a calendar, and know, with at least 90% certainty, that you could cash in on that day. (ad)[Learn all the details here.]( Featured Stock [Molecular Templates, Inc. (MTEM) – Buy Target – $15.50 or better]( Molecular Templates, Inc., a clinical stage oncology company, focuses on   the discovery and development of biologic therapeutics for the   treatment of cancer and other diseases. The company primarily develops a   pipeline of engineered toxin bodies. Other Top Stories [Stocks open higher on Wall Street; China's main market dives]( [Survey: U.S. factories expand for first time since July]( [3rd worker dies of injuries from Texas oil well blowout]( [WHO working with Google to combat virus misinformation](  Sponsor [Options Genius Reveals 100% Profit Target Strategy (Every Week)]( 100% profit targets weekly - Options Genius shares his simple system to profit on options trades every single week with just 1 trade. If you are looking for 1 perfect trading idea to generate consistent profits you have to watch his short video. [Watch this video now.](  Trend Following Picks [(CNNE) – Buy Target – $41.00 or better]( [(MLSS) – Buy Target – $1.80 or better]( [(CLSD) – Buy Target – $3.30 or better]( [(CDTX) Buy Target – $4.25 or better]( [(EVER) – Buy Target – $39.00 or better]( [All Picks]( Reversal Picks [(DCIX) Buy Target $0.87  Sell Target $0.95]( [(AKTX) Buy Target $2.05  Sell Target $2.28]( [(AQMS) Buy Target $0.96  Sell Target $1.29]( [(SPRO) Buy Target $10.16  Sell Target $11.04]( [(SOL) Buy Target $1.45  Sell Target $1.58]( [All Picks](  Already subscribed to our premium service? [Click here to Login]( Not a TradersPro subscriber yet? [Learn More About TradersPro Here -  Learn The # 1 Key To Successful Stock Investing Profits](                                --------------------------------------------------------------- This email was sent to {EMAIL} by Investiv, LLC 265 N. Main | Ste. D #283 | Kaysville | UT | 84037 [Forward to a friend]( | [Unsubscribe]( or [Mange which emails you get from TradersPro]( Disclaimers Investing is Inherently Risky There are risks inherent in all investments, which may make such investments unsuitable for certain persons. These include, for example, economic, political, currency exchange, rate fluctuations, and limited availability of information on international securities. You may lose all of your money trading and investing. Do NOT enter any trade without fully understanding the worst-case scenarios of that trade. And do NOT trade with money you cannot afford to lose. Past performance of an investment is not necessarily indicative of its future results. No assurance can be given that any implied recommendation will be profitable or will not be subject to losses. Hypothetical Results Are Reported Results and examples used in the Company’s advertisements, books, videos, websites, and other media—including on the Site and the Network—are, in some cases, based on hypothetical (simulated) trades. Plainly speaking, these trades were not actually executed. Hypothetical performance results have certain limitations. Unlike an actual performance record, hypothetical results do not represent actual trading. Also, since the trades have not been executed, the hypothetical results may have under-or-over compensation for the impact, if any, of certain market factors, such as lack of liquidity. Hypothetical trading programs generally are also subject to the fact that they are designed with the benefit of hindsight. Hypothetical results also do not account for commissions or slippage. The Company’s simulations assume purchase and sale prices believed to be attainable. Yet traders are going to be getting into trades at different times and using various exit approaches, which may result in different pricing and outcomes. You may or may not receive the best available price on the purchase or the sale of a position in actual trading. Information provided by the Company is not investment advice. The Company is not a registered investment adviser, stock broker, or brokerage. You agree that the Company does not represent, warrant, or take responsibility that any account will or is likely to achieve profit or losses similar to those shown. Examples published by the Company are selected for illustrative purposes only. They are not typical and do not represent the typical results of all stocks within the Company’s software or its individual scans and searches. No independent party has audited any hypothetical performance contained at this Web site, nor has any independent party undertaken to confirm that they reflect the trading method under the assumptions or conditions specified. Offers Disinterested Commentary and Analysis The Company does not receive any form of payment or other compensation for publishing information, news, research, or any other material concerning specific securities on the Network that is intended to affect or influence the value of securities. The Company, and its personnel, do not engage in front-running of recommendations and do not trade against one’s own recommendations. The Company and its management may benefit from an increase or decrease in the share prices of the profiled companies, and/or may have other actual or potential conflicts of interest. If a particular security featured in a newsletter publication is concurrently owned by the Company in its corporate brokerage account, or in any of the individual accounts of the Company’s principals or analysts / writers, that fact will be disclosed. The Company, its principals, analysts and writers may choose to purchase a security or derivative featured in one of its newsletter publications, but typically will wait three (3) trading days from the date of publication before initiating said purchase. [Disclaimers, Terms & Conditions]( | [Privacy Policy]( Copyright © 2019